Atlas Trials

Prospectively Predict the Efficacy of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy

Clinical trial NCT04993378 · UNKNOWN

Trial details

NCT number
NCT04993378
Sponsor
Shen Lin
Status
UNKNOWN
Study type
OBSERVATIONAL
Advanced Gastric AdenocarcinomaImmunotherapy
Start date
2018-11-01
Primary completion
2021-04-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.